New evidence supports the value of preventive care profiles on all adult dogs
Dogs as young as 2 years of age had clinically significant findings based on results of preventive care bloodwork and fecal testing1
Of the nearly 30,000 canine profiles included in this analysis, there was little variation in the rate of clinically significant findings between adult dogs and senior dogs. The study was based on an analysis of IDEXX Preventive Care profiles (including the following categories: Chem 22 including the IDEXX SDMA® Test, IDEXX CBC testing with reticulocyte parameters, the Lab 4Dx® Plus Test, and Fecal Dx® antigen testing) run as part of wellness visits. While the number of clinically significant findings for each of these testing categories varied by age, all categories were important for adult, senior, and geriatric dogs.
These results are similar to a previous analysis that included cats as young as 2 years2
The previous analysis from more than a quarter of a million wellness visits that included a chemistry profile with an IDEXX SDMA® Test and a CBC, revealed significant findings required follow-up in:
1 in 7 adults (cats aged 2–8 years; dogs aged 3–6 years)
1 in 5 seniors (cats aged 9–13 years; dogs aged 7–10 years)
2 in 5 geriatrics (cats aged 14+ years; dogs aged 11+ years)
Routine preventive care testing has distinct medical benefits
There is ample evidence to support routine preventive care visits that include diagnostic testing. Results of routine bloodwork and fecal testing help veterinarians detect diseases and conditions, leading to earlier interventions that help patients of all ages live healthy lives for as long as possible. Once a veterinarian has baseline values, she/he can monitor trends and, if necessary, create individualized treatment plans. If no abnormality is detected, veterinarians and staff can—and should—celebrate the good news with clients. By communicating the value of every test result, practices reinforce the importance of routine wellness checks and the central role that clients play in the health of their pet. It’s a win-win!
*Due to “clinically significant findings,” which would indicate the need for follow-up, further consideration, or a change in action by the clinician. Clinical significance based on rules determined by an IDEXX veterinarian panel.
- Data based on analyses of 29,795 canine wellness profiles (Chem 22 including IDEXX SDMA® Test, IDEXX CBC testing with reticulocyte parameters, the Lab 4Dx® Plus Test, and Fecal Dx® antigen testing) associated with wellness visits; testing performed at IDEXX Reference Laboratories on July 13, 2016–February 28, 2019. Represented U.S. regions by proportion of included profiles: Northeast (32.0%), South (41.3%), Midwest (17.4%), West (7.6%), and region not reported (1.7%).
- Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA.
© 2020 IDEXX Laboratories, Inc. All rights reserved.